Patents from Oncopia Therapeutics Inc. (dba SK Life Science Labs) describe proteolysis targeting chimeric (PROTACs) compounds reported to be useful for the treatment of cancer, autoimmune and ...

First patient dosed in phase 1b/2a trial for castration-resistant metastatic prostate cancer, evaluating pocenbrodib alone ...

The combination of ADT and SBRT significantly improved clinical and biochemical PFS compared to SBRT alone in hormone-sensitive prostate cancer. Median clinical PFS was 32.2 months with ADT plus SBRT ...

Impact of Insurance Status on Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma This retrospective analysis included patients with cancer who had commercial ctDNA tests (K-Track, Gene ...

Loss of articular cartilage caused by extracellular matrix breakdown is the hallmark of arthritis. Degradative fragments of cartilage oligomeric matrix protein (COMP) have been observed in ...

ABO-101 received orphan drug and rare pediatric disease designations for PH1, targeting the HAO1 gene to reduce oxalate production. Ibex Prostate Detect, an AI-powered diagnostic tool, achieved 510(k) ...